Register Now
Login to Partnering
Youtube Linkedin Facebook
DxPx focuses solely on Diagnostics, Digital Health, Precision Medicine & Life Science Tools
The founders of DxPx are all startup entrepreneurs and former industry executives.
This conference was born to fill a gap. To answer a need. To help you change the future of our industries.

450 Decision Makers
1.300 Meetings
45 Speakers
Learn More
co-operate | co-invest | co-meet

Promoting startups and growth companies is the heart and soul of DxPx.
Meet hundreds of potential co-investors; where else would you find the opportunity
to pack 20 meetings in one day?
Discuss Licensing and M&A Opportunities. Meet co-investors. Expand your deal-flow.

While most people will talk the talk, few will walk the walk;
be amongst those few.

Unlimited access to our partnering tool and meeting spaces (virtual/on-site).
Join Dxpx
Discover the Latest Trends.
DxPx was first hosted in 2019 as an international Industry & Investor Partnering Conference for executives from our niche to explore
financing, licensing, and M&A opportunities.
The annual flagship conference takes place each November in Dusseldorf, Germany and is accompanied with satellite conferences
in the US and China throughout the year. 
Our Investors
Ready?

  • Unlimited access to our partnering tool and meeting spaces (virtual/on-site).
  • Access to all panel discussions and company presentations.
  • Access to exhibition and networking area.
  • Access to DxPx Award ceremony and reception

    For a free ticket for eligible investors contact us at info@dxpx-conference.com
    • Get your ticket

    join. network. Grow.

    With the gaining importance of diagnostics, digital health, precision medicine and life science tools there is a need for a dedicated platform to bring together the relevant stakeholders
    and further drive our industries. 

    Days
    Hours
    Minutes
    Seconds

    On November 16th, 2021, parallel to MEDICA, the World Forum for Medicine, the DxPx Conference will bring together startups and growth companies as well as established industry companies and investors to a diagnostics, digital health, precision medicine and life science tools partnering conference.

    The DxPx Conference Series:

    The paramount importance of diagnostics, digital health, precision medicine and life science tools, dictate the need for a dedicated platform.
    DxPx brings together the relevant stakeholders
    and further drives our industries.
    DxPx is hosted as an annual international partnering conference to facilitate licensing, financing, co-development and M&A opportunities and celebrates great success and fast growth.

    At a Glance:

    Date: November 16th, 2021.
    Place: Düsseldorf.
    Open for: Start-Ups, Growth Companies,
    established industry companies and investors
    Online: 8 days digital partnering Nov 12th – 20th, 2021
    Learn More

    co-operate | co-invest | co-meet

    "Being a part of a Start-Up
    is like trying to build a bike, while riding it."

    To help innovative companies meet as many investors as possible we are happy to register one investor per company free of charge.

    Find your next collaborator.

    Your Next Steps:

    Secure your DxPx ticket.
    Submit your pitch to 42PLUS1.
    Showcase your business with a DxPx exhibition booth.

    Whatever you're thinking, think bigger.
    Join DxPx

    Discover the Latest Trends:

    The 42PLUS1 Award brings together the most promising start-ups and growth companies to compete at our DxPx Flagship Conference for at least $2,000,000.

    The funding will be granted to the three winners as convertible loan to build further value for the next financing round.

    Finding Funding:

    Diagnostics, Digital Health, Precision Medicine & Life Science Tools industries are undergoing a transformation, and it is imperative to leverage new technologies, innovation and business acumen.
    Explore

    Ready?!

    If you know what to expect, why procrastinate?

    One ticket unlocks a myriad of opportunities.

    Our proven partnering tool allows efficient matchmaking upfront and lets you schedule meetings with visionaries and newcomers from all over the world.

    Tailor-made Offers for:

  • Technology Transfer Offices & Press
  • Investors & Industry Leaders
  • Startups & Growth Companies
    and more:
    • Get Your Ticket

    Don't miss our investor conferences & early-stage investing events:

    dxpx us adlm logos
    DxPx US

    DxPx Industry & Investor Conference US:
    4 Days In-Person

    July 29 - Aug. 1, 2024
    Chicago, IL
    In the ADLM

    Stay up to date and sign up for our latest news:

    Next: DxPx U.S. 2025
    • 3 Days In-Person
    • July 29 - 31, 2025
    • McCormick Place
      Convention Center
      Chicago, Illinois, USA
    Next: DxPx EU 2026
    • 2 Days In-Person
    • Reception: February 5, 2026
      Partnering Day & 42PLUS1:
      February 6, 2026
    • Munich, Germany
    Download Brochure
    DxPx media
    Useful links

    © Copyright DxPx 2025. All Rights Reserved.

    Youtube Linkedin Facebook

    Oliver Dick

    Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

    Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

    Experience

    Christoph Brandenberger

    Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

    A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

    Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

    Experience

    John Riddle

    John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

    John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

    Experience

    Dr. Mirko Stange

    Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

    In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

    Experience

    FName LName

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

    Experience